Oral Decitabine/Cedazuridine Vs Intravenous Decitabine for Acute Myeloid Leukemia: Final Results of a Randomized, Crossover, Registration-Enabling, Pharmacokinetics Study

被引：0

作者：

Geissler, Klaus ^{[1
,2
]}

Koristek, Zdenek ^{[3
]}

Del Castillo, Teresa Bernal ^{[4
]}

Novak, Jan ^{[5
,6
]}

Macias, Gabriela Rodriguez ^{[7
]}

Metzelder, Stephan ^{[8
]}

Illes, Arpad ^{[9
]}

Nagy, Agnes ^{[10
]}

Mayer, Jiri ^{[11
,12
]}

Arnan Sangerman, Montserrat ^{[13
]}

Keating, Mary-Margaret ^{[14
]}

Krauter, Juergen ^{[15
]}

Lunghi, Monia ^{[16
]}

Fracchiolla, Nicola ^{[17
]}

Platzbecker, Uwe ^{[18
]}

Santini, Valeria ^{[19
]}

Chan, Danna ^{[20
]}

Mirakhur, Beloo ^{[20
]}

Sano, Yuri ^{[20
]}

Oganesian, Aram ^{[20
]}

Keer, Harold N. ^{[20
]}

Luebbert, Michael ^{[21
]}

机构：

[1] Clin Hietzing, Vienna, Austria

[2] Sigmund Freud Univ, Vienna, Austria

[3] Univ Hosp Ostrava, Ostrava, Czech Republic

[4] Hosp Univ Cent Asturias, ISPA, IUOPA, Oviedo, Spain

[5] Charles Univ Prague, Prague, Czech Republic

[6] Fac Hosp Kralovske Vinohrady, Prague, Czech Republic

[7] Hosp Univ Gregorio Maranon, Madrid, Spain

[8] Philipps Univ Marburg, Marburg, Germany

[9] Univ Debrecen, Dept Hematol, Fac Med, Debrecen, Hungary

[10] Univ Pecs, Pecs, Hungary

[11] Masaryk Univ, Brno, Czech Republic

[12] Univ Hosp Brno, Brno, Czech Republic

[13] Univ Barcelona, Dept Hematol, Inst Catala Oncol, Hosp Duran & Reynals,Inst Invest Biomed Bellvitge, Barcelona, Spain

[14] Queen Elizabeth II QEII Hlth Sci Ctr, Halifax, NS, Canada

[15] Stadt Klinikum Braunschweig, Dept Hematol & Oncol, Braunschweig, Germany

[16] Univ Piemonte Orientale, Dept Translat Med, Div Hematol, Novara, Italy

[17] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Hematol Unit, Milan, Italy

[18] Univ Hosp Leipzig, Dept Hematol, Leipzig, Germany

[19] Univ Florence, DMSC, AOU Careggi, MDS Unit, Florence, Italy

[20] Astex Pharmaceut Inc, Pleasanton, CA USA

[21] Univ Med Ctr Freiburg, Freiburg, Germany

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-173092

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[21] Final Report of a Randomized Study of Decitabine Versus Conventional Care (CC) for Maintenance Therapy in Patients with Intermediate and High Risk Acute Myeloid Leukemia (AML) in First or Subsequent Complete Remission (CR)
Boumber, Yanis
Issa, Jean-Pierre
Jorgensen, Jeffrey L.
Faderl, Stefan
Castoro, Ryan J.
Autry, Jane
Garcia-Manero, Guillermo
Borthakur, Gautam
Jabbour, Elias
Estrov, Zeev
Cortes, Jorge E.
Kantarjian, Hagop M.
Ravandi, Farhad
BLOOD, 2011, 118 (21) : 664 - 665
[22] Phase 2 Study of ASTX727 (cedazuridine/decitabine) Plus Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) or Previously Untreated, Elderly Patients with AML Unfit for Chemotherapy
Abuasab, Tareq
Garcia-Manero, Guillermo
Short, Nicholas
Alvarado, Yesid
Issa, Ghayas C.
Islam, Rubiul
Maiti, Abhishek
Yilmaz, Musa
Jain, Nitin
Masarova, Lucia
Kornblau, Steven M.
Jabbour, Elias
Pemmaraju, Naveen
Montalban-Bravo, Guillermo
Pierce, Sherry A.
DiNardo, Courtney D.
Kadia, Tapan M.
Daver, Naval
Konopleva, Marina
Kantarjian, Hagop
Ravandi, Farhad
BLOOD, 2022, 140 : 3324 - 3326
[23] Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 x 2, Phase II Trial
Luebbert, Michael
Grishina, Olga
Schmoor, Claudia
Schlenk, Richard F.
Jost, Edgar
Crysandt, Martina
Heuser, Michael
Thol, Felicitas
Salih, Helmut R.
Schittenhelm, Marcus M.
Germing, Ulrich
Kuendgen, Andrea
Goetze, Katharina S.
Lindemann, Hans-Walter
Mueller-Tidow, Carsten
Heil, Gerhard
Scholl, Sebastian
Bug, Gesine
Schwaenen, Carsten
Giagounidis, Aristoteles
Neubauer, Andreas
Krauter, Juergen
Brugger, Wolfram
De Wit, Maike
Waesch, Ralph
Becker, Heiko
May, Annette M.
Duyster, Justus
Doehner, Konstanze
Ganser, Arnold
Hackanson, Bjoern
Doehner, Hartmut
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (03) : 257 - +
[24] Decitabine/Cedazuridine (ASTX727) Combined with a Molecularly-Targeted Agent (Venetoclax, Gilteritinib, Ivosidenib, or Enasidenib) As Personalized Maintenance Therapy in Acute Myeloid Leukemia: First Results from a Phase 1b Study
Bazinet, Alexandre
Kantarjian, Hagop M.
Ravandi, Farhad
Short, Nicholas J.
Daver, Naval
Ohanian, Maro
Yilmaz, Musa
Chien, Kelly S.
Maiti, Abhishek
DiNardo, Courtney D.
Ishizawa, Jo
Masarova, Lucia
Bull-Linderman, Debra
Borthakur, Gautam
Jabbour, Elias
Garcia-Manero, Guillermo
Kadia, Tapan M.
BLOOD, 2023, 142
[25] Phase Ib/II Study (NCT02488408 / BGBC003) of Bemcentinib Monotherapy or in Combination with Cytarabine or Decitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): FINAL Results
Loges, Sonja
Heuser, Michael
Chromik, Jolanta
Sutamtewagul, Grerk
Kapp-Schwoerer, Silke
Crugnola, Monica
Di Renzo, Nicola
Lemoli, Roberto Massimo
Mattei, Daniele Giovanni
Ben Batalla, Isabel
Waizenegger, Jonas
Janning, Melanie
Rieckmann, Lisa-Marie
Imbusch, Charles
Beumer, Niklas
Micklam, David
Gorcea-Carson, Claudia
Oliva, Cristina
Fiedler, Walter
Alvarado-Valero, Yesid
McCracken, Nigel
Gjertsen, Bjorn T.
BLOOD, 2023, 142
[26] Randomized study of decitabine versus observation or continued cytotoxic chemotherapy in patients with intermediate and poor risk acute myeloid leukemia in first or subsequent complete remission
Ravandi, Farhad
Issa, Jean-Pierre
Faderl, Stefan
Garcia-Manero, Guillermo
Hood, Mary
Jorgensen, Jeffrey
Lee, Ming
O'Brien, Susan
Estey, Elihu
Borthakur, Gautam
Ferrajoli, Alessandra
Verstovsek, Srdan
Corbes, Jorge
Kantarjian, Hagop
BLOOD, 2007, 110 (11) : 841A - 841A
[27] Results of Phase 2 Randomized Study of Low-Dose Decitabine With or Without Valproic Acid in Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia
Issa, Jean-Pierre
Garcia-Manero, Guillermo
Huang, Xuelin
Cortes, Jorge
Ravandi, Farhad
Jabbour, Elias
Borthakur, Gautam
Brandt, Mark
Pierce, Sherry
Kantarjian, Hagop M.
CANCER, 2015, 121 (04) : 556 - 561
[28] Long-Term Subgroup Analyses from Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry
Labrador, Jorge
la Fuente, Adolfode
Martinez-Cuadron, David
Rodriguez-Veiga, Rebeca
Serrano, Josefina
Tormo, Mar
Perez-Simon, Jose
Ramos, Fernando
del Castillo, Teresa Bernal
Lopez-Pavia, Maria
Trigo, Fernanda
Sanchez, Pilar Martinez
Rodriguez-Gutierrez, Juan Ignacio
Rodriguez, Carlos
Gil, Cristina
Garcia, Daniel
Vives, Susana
Foncillas, Maria Angeles
Encinas, Manuel Perez
Novo, Andres
Recio, Isabel
Macias, Gabriela Rodriguez
Burgues, Juan Miguel Bergua
Concepcion, Victor Noriega
Lavilla, Esperanza
Perez, Alicia Roldan
Sanz, Miguel A.
Montesinos, Pau
BLOOD, 2021, 138
[29] Phase 2 study of ASTX727 (cedazuridine/decitabine) plus venetoclax (ven) in patients with relapsed/refractory acute myeloid leukemia (AML) or previously untreated, elderly patients (pts) unfit for chemotherapy.
Ravandi, Farhad
Abuasab, Tareq
Valero, Yesid Alvarado
Issa, Ghayas C.
Islam, Rabiul
Short, Nicholas James
Yilmaz, Musa
Jain, Nitin
Masarova, Lucia
Kornblau, Steven Mitchell
Jabbour, Elias
Pemmaraju, Naveen
Bravo, Guillermo Montalban
Pierce, Sherry
Dinardo, Courtney Denton
Kadia, Tapan M.
Daver, Naval Guastad
Konopleva, Marina
Garcia-Manero, Guillermo
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[30] Preliminary Results of a Phase II Study of Low Dose Decitabine as a Single Agent in Older Patients (age≥60) with Previously Untreated Acute Myeloid Leukemia (AML)
Blum, William
Klisovic, Rebecca
Liu, Shujun
Garzon, Ramiro
Kefauver, Cheryl
Liu, Zhongfa
Mickle, Jon
Devine, Hollie
Devine, Steve
Grever, Michael R.
Chan, Kenneth K.
Villalona-Calero, Miguel
Byrd, John C.
Marcucci, Guido
BLOOD, 2008, 112 (11) : 1016 - 1016

← 1 2 3 4 5 →